The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/30609
StudyName: Eligibility Breast Neoplasms NCT01026116
Date of export from the portal: 02.07.2020
Copyright Holder: see clinicaltrials.gov
Date of Upload / last change: 18.06.2018
License: Creative Commons BY 4.0

----

Description: 
A Randomized Trial Comparing Epirubicin/Cyclophosphamide Followed by Weekly Paclitaxel Versus Epirubicin/Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for Operable Breast Cancer Patients Less Than 40 Years Old; ODM derived from: https://clinicaltrials.gov/show/NCT01026116
